Literature DB >> 19871351

VARIATION IN MORBIDITY AND MORTALITY OF MURINE TYPHUS INFECTION IN MICE WITH CHANGES IN THE ENVIRONMENTAL TEMPERATURE.

V Moragues1, H Pinkerton.   

Abstract

Murine typhus rickettsiae injected intraperitoneally in mice of the dba strain caused a uniformly fatal rickettsial peritonitis if the animals were kept at a room temperature ranging from 65-73 degrees F. or from 70-80 degrees F. With an environmental temperature range of 85-98 degrees F., a mortality of less than 25 per cent was observed. By utilizing different strains of mice and controlling the environmental temperature, conditions may be created under which murine typhus will have any desired degree of mortality. Such conditions have obvious advantages for the evaluation of therapeutic measures in typhus infection.

Entities:  

Year:  1944        PMID: 19871351      PMCID: PMC2135429          DOI: 10.1084/jem.79.1.41

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

Review 1.  Warming the mouse to model human diseases.

Authors:  Kirthana Ganeshan; Ajay Chawla
Journal:  Nat Rev Endocrinol       Date:  2017-05-12       Impact factor: 43.330

Review 2.  Temperature matters! And why it should matter to tumor immunologists.

Authors:  Elizabeth A Repasky; Sharon S Evans; Mark W Dewhirst
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

3.  Thermoneutral Housing Accelerates Metabolic Inflammation to Potentiate Atherosclerosis but Not Insulin Resistance.

Authors:  Xiao Yu Tian; Kirthana Ganeshan; Cynthia Hong; Khoa D Nguyen; Yifu Qiu; Jason Kim; Rajendra K Tangirala; Peter Tontonoz; Peter Tonotonoz; Ajay Chawla
Journal:  Cell Metab       Date:  2015-11-05       Impact factor: 27.287

4.  Unstressing intemperate models: how cold stress undermines mouse modeling.

Authors:  Christopher L Karp
Journal:  J Exp Med       Date:  2012-06-04       Impact factor: 14.307

5.  The Impact of Housing Temperature-Induced Chronic Stress on Preclinical Mouse Tumor Models and Therapeutic Responses: An Important Role for the Nervous System.

Authors:  Bonnie L Hylander; Jason W-L Eng; Elizabeth A Repasky
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 3.650

6.  Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL/6 mice.

Authors:  Daniel A Giles; Bhama Ramkhelawon; Elizabeth M Donelan; Traci E Stankiewicz; Susan B Hutchison; Rajib Mukherjee; Monica Cappelletti; Rebekah Karns; Christopher L Karp; Kathryn J Moore; Senad Divanovic
Journal:  Mol Metab       Date:  2016-09-21       Impact factor: 7.422

7.  Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.

Authors:  Daniel A Giles; Maria E Moreno-Fernandez; Traci E Stankiewicz; Simon Graspeuntner; Monica Cappelletti; David Wu; Rajib Mukherjee; Calvin C Chan; Matthew J Lawson; Jared Klarquist; Annika Sünderhauf; Samir Softic; C Ronald Kahn; Kerstin Stemmer; Yoichiro Iwakura; Bruce J Aronow; Rebekah Karns; Kris A Steinbrecher; Christopher L Karp; Rachel Sheridan; Shiva K Shanmukhappa; Damien Reynaud; David B Haslam; Christian Sina; Jan Rupp; Simon P Hogan; Senad Divanovic
Journal:  Nat Med       Date:  2017-06-12       Impact factor: 53.440

8.  THERAPEUTIC EFFECTIVENESS OF PENICILLIN IN EXPERIMENTAL MURINE TYPHUS INFECTION IN dba MICE.

Authors:  V Moragues; H Pinkerton; D Greiff
Journal:  J Exp Med       Date:  1944-04-01       Impact factor: 14.307

9.  EFFECT OF ENZYME INHIBITORS AND ACTIVATORS ON THE MULTIPLICATION OF TYPHUS RICKETTSIAE : I. PENICILLIN, PARA-AMINOBENZOIC ACID, SODIUM FLUORIDE, AND VITAMINS OF THE B GROUP.

Authors:  D Greiff; H Pinkerton; V Moragues
Journal:  J Exp Med       Date:  1944-12-01       Impact factor: 14.307

10.  THE ANTIRICKETTSIAL EFFECT OF THIONINE DYES : I. THE USE OF METHYLENE BLUE AND TOLUIDINE BLUE TO COMBAT EXPERIMENTAL TSUTSUGAMUSHI DISEASE (SCRUB TYPHUS).

Authors:  O L Peterson; J P Fox
Journal:  J Exp Med       Date:  1947-04-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.